Table 3.
Increased expression of NK cell related genes in peripheral blood from children with autism spectrum disorder compared with typically developing controls using microarray analysis.
Fold-change | Gene Name | Protein Name |
---|---|---|
2.2 | CCL4 | MIP-1 Beta |
1.7 | CCL5 | RANTES |
1.7 | CD160 | CD160 |
2.4 | CTSW | Cathepsin W/Lymphopain |
1.8 | CX3CR1 | Chemokine (CX3C motif) receptor 1 |
2.7 | GZMB | Granzyme B |
2.4 | GZMH | Granzyme H |
1.5 | GZMM | Granzyme M |
1.9 | IL2RB | Interleukin 2 receptor beta |
2.1 | ITGB2 | CD18/Beta 2 integrin |
1.5 | KIR2DL1 | KIR, two domains, long cytoplasmic tail |
1.7 | KIR2DL2 | |
1.5 | KIR2DL3 | |
1.6 | KIR2DL5A | |
2.2 | KIR2DS2 | KIR, two domains, short cytoplasmic tail |
1.7 | KIR2DS5 | |
1.7 | KIR3DL1 | KIR, three domains, long cytoplasmic tail |
1.7 | KIR3DL2 | |
1.7 | KIR3DL3 | |
1.8 | KLRD1 | CD94 |
1.7 | KLRF1 | ITIM2 |
2.5 | KSP37 | KSP37 protein |
1.5 | NFATC2 | Nuclear factor of activated T cells |
2.5 | NKG7 | Natural killer cell group 7, sequence |
1.9 | PDGFD | Platelet derived growth factor D |
2.6 | PRF1 | Perforin 1 |
2.2 | PTGDR | prostaglandin D2 receptor |
2.0 | TBX21 | T-box 21/TBET |
2.0 | TGFBR3 | Transforming growth factor β receptor III |
1.6 | TRGC2 | T cell receptor gamma constant 2 |